Investing.com investing.com 02 Jan, 2021 12:15 am

India approves AstraZeneca's COVID-19 vaccine By Reuters

India approves AstraZeneca's COVID-19 vaccine By Reuters
India approves AstraZeneca's COVID-19 vaccine

Das NEW DELHI (Reuters) - India has approved the COVID-19 vaccine developed by AstraZeneca (NASDAQ: AZN ) and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country.It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States, and comes on the day the country is running a nationwide mock drill for vaccine delivery.India's regulator has also received an emergency-use application for the COVID-19 vaccine made by Pfizer Inc (NYSE: PFE ) with Germany's BioNTech - the first shot to secure regulatory approval in the West.Japan to consider new COVID-19 emergency declaration p TOKYO (Reuters) - Japan will consider issuing a new emergency declaration after governors in the capital region urged action to tackle a record surge in COVID-19 cases, the head.

" he said, referring to the fact that the AstraZeneca/Oxford shot is being made locally by the Serum Institute of India (SII).SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses of the AstraZeneca/Oxford shot, which will be sold to the government at about 250 rupees ($3.

Read full story at investing.com